700019Human Lymphoma TestClosedGRD Proof of MarketInnovate UKPredictive Life Sciences wishes to undertake a market research exercise and assess the viability of taking a novel diagnostic test initially developed for canine lymphoma and explore the application of the test for human application. Our test detects biomarkers that are unique to lymphoma in dogs and humans using the latest biomarker discovery technology. Through our sister company Petscreen Ltd we have successfully developed a working model which facilitates efficient biomarker discovery, characterisation and translation onto a standard immunoassay platform used by all diagnostics laboratories globally. We recognise that the market for our test for human application has enormous potential, and we wish to undertake detailed market research, competitor analysis and business modelling to create a route map for commercialising our technology for the human market.